English

News

<< < Previous 123Page 3 / 3

Revolutionizing Diagnostics with Intelligent CPET & Stress ECG Technology

Analyzing cardiac activity under physical stress is vital for early coronary and respiratory diagnoses. Our research updates highlight how we are revolutionizing cardiopulmonary monitoring through the future of iCPET (Intelligent Cardiopulmonary Exercise Test) technology. By combining high-precision metabolic gas exchange monitoring with wireless 12-lead stress ECGs, our iCPET systems provide clinicians with standardized, computer-aided reports that evaluate cardiopulmonary capacity, establish precise rehabilitation benchmarks, and detect silent myocardial ischemia.

Global Medical Presence: ESC Congress, CMEF & Certification Milestones

For more than twenty years, V&H Biomedical has remained at the forefront of global diagnostic innovation. Our corporate updates cover our academic presence at major medical gatherings, such as presenting our cardiovascular health advocacy at the European Society of Cardiology (ESC) Congress and showcasing smart spirometry and cardiac AI at the China International Medical Equipment Fair (CMEF). These articles reflect our commitment to continuous research, standard-setting medical certifications, and international collaborations designed to elevate patient care.

Frequently Asked Questions

What kind of clinical resources can I access in the V&H Biomedical News section?

Our news section provides valuable clinical resources, including step-by-step setup and workflow guides for portable Bluetooth ECG systems (such as the iCV200S for iOS), technical purchasing guides for 12-lead diagnostic hardware, and in-depth analyses explaining the medical significance of continuous Holter monitoring and cardiopulmonary exercise testing (iCPET).

What is V&H's "iCPET" technology, and what are its clinical applications?

As featured in our technology updates, iCPET (Intelligent Cardiopulmonary Exercise Test) is an advanced diagnostic platform that integrates high-precision metabolic analysis with real-time stress electrocardiography. It is primarily used to evaluate patient cardiopulmonary reserve, diagnose unexplained dyspnea, assess cardiovascular disease risks, and establish highly customized exercise and rehabilitation prescriptions in clinical, sports medicine, and research settings.

Where does V&H Biomedical present its latest cardiac and pulmonary innovations globally?

We regularly share updates regarding our active participation in premier global medical exhibitions and academic congresses. This includes showcasing our wireless cardiac biosensors and portable spirometers at the China International Medical Equipment Fair (CMEF) and discussing global health landscapes and AI-powered cardiac diagnostics at the annual ESC (European Society of Cardiology) Congress.

vhekg contact form